A New Option to Reduce Strokes in Patients With Atrial Fibrillation (Afib) – Watchman Device
Patients with atrial fibrillation (AFib) have on average a five-fold higher risk of having a stroke. Most strokes are caused by blood clots that originate in the left atrial appendage.
Traditionally, blood thinners have been used to reduce the risk of strokes in patients with AFib. However, these medications may cause side effects, and also increase the risk of bleeding.
Left atrial appendage closure using a device is a good alternative for patients who are not able to take blood thinners for a long time. The WATCHMAN LAAC Device offers a new stroke risk reduction option for patients with non-valvular atrial fibrillation who are seeking an alternative to long-term oral anticoagulation therapy.
Please watch our presentation to learn more about Afib and the WATCHMAN™ LAAC Device.
Bill’s WATCHMAN Story
Patients with AFib have a five-fold increased risk of stroke due to blood stagnating from the improperly beating atrium and the resulting blood clot formation. This device is a potential alternative to long-term oral anticoagulation to reduce the risk of stroke related to AFib.
Atrial Fibrillation (Afib) is a condition that can impact your quality of life and cause strokes. Afib treatment should be individualized to meet each patient’s needs.
Dr Jose Osorio
Read More About AFib: